Home/REGN/Growth Rates

REGN Growth Rates - Revenue & Earnings Growth

Comprehensive analysis of Regeneron Pharmaceuticals Inc growth metrics including revenue, earnings, and EPS growth rates.

REGNHealthcare
Revenue Growth
0.0%
Year-over-year
2.3% CAGR (4yr)
Earnings Growth
0.0%
Year-over-year
3.3% CAGR (4yr)
EPS Growth
$43.07
Latest EPS
3.8% CAGR (4yr)

Growth Summary

Regeneron Pharmaceuticals Inc (REGN) has shown a revenue growth rate of 0.0% year-over-year. Earnings have grown by 0.0% in the same period.

Over the past 4 years, Regeneron Pharmaceuticals Inc has delivered a compound annual growth rate (CAGR) of 2.3% for revenue and 3.3% for earnings.

Revenue & Earnings Trends

Historical revenue and net income for Regeneron Pharmaceuticals Inc

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Earnings Per Share (EPS) Growth

Historical EPS trends for Regeneron Pharmaceuticals Inc

Earnings per share (EPS) is a key metric that shows how much profit Regeneron Pharmaceuticals Inc generates for each share of stock. Over the past 4 years, EPS has grown at a CAGR of 3.8%.

Related Analysis

REGN Overview
Complete stock analysis
Earnings Calendar
Upcoming earnings dates
Financial Statements
Income, balance sheet, cash flow